Skip to content
← Full study record

NCT00085735 · OUTCOME

Overall Survival (OS)

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma · Source last updated 2026-06-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability of 3 yr OS rate
Interval / dispersion
95% Confidence Interval
Time frame
3 years

What was measured

OS was defined as the time interval from date of study entry to date of death from any cause or to the date of last follow-up for survivors. OS was estimated using the method of Kaplan and Meier. 3-year estimates are reported with 95% CI's. For purposes of this analysis, arms I, III and V (involved field radiation therapy \[IFRT\]) are combined and compared to arms II, IV and VI (posterior fossa irradiation \[PFRT\]).

Analysis population: Per protocol only eligible \& evaluable pts were included.Pts with anaplastic histology or disseminated/excess residual disease were not evaluable (NE). 26/23 IFRT/PFRT pts were NE, leaving 227 vs 237 for this comparison. The LD/SD CSI comparison was done only in pts 3-7 yrs of age. 11/8 LD/SDCSI pts were NE, leaving 116 vs 110 for this comparison.

Groups in this outcome

Low-dose Craniospinal Radiation (LDSCI)

Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II)

Standard-dose Craniospinal Radiation (SDCSI)

Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV)

Involved Field Radiation (IFRT)

Includes eligible patients 3-21 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the IFRT arms (Treatment Arms I, III, V)

Posterior Fossa Radiation (PFRT)

Includes eligible patients 3-21 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the PFRT arms (Treatment Arms II, IV, VI)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Low-dose Craniospinal Radiation (LDSCI)116
Standard-dose Craniospinal Radiation (SDCSI)110
Involved Field Radiation (IFRT)227
Posterior Fossa Radiation (PFRT)237

Reported measurements

IFRT vs PFRT

Analysis denominator · Participants

GroupSource count
Low-dose Craniospinal Radiation (LDSCI)0
Standard-dose Craniospinal Radiation (SDCSI)0
Involved Field Radiation (IFRT)227
Posterior Fossa Radiation (PFRT)237
Values in Probability of 3 yr OS rate · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Involved Field Radiation (IFRT)90.3Not reported86.294.4Not reported
Posterior Fossa Radiation (PFRT)93.3Not reported90.096.6Not reported
LDCSI vs SDCSI

Analysis denominator · Participants

GroupSource count
Low-dose Craniospinal Radiation (LDSCI)116
Standard-dose Craniospinal Radiation (SDCSI)110
Involved Field Radiation (IFRT)0
Posterior Fossa Radiation (PFRT)0
Values in Probability of 3 yr OS rate · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Low-dose Craniospinal Radiation (LDSCI)85.5Not reported78.492.6Not reported
Standard-dose Craniospinal Radiation (SDCSI)90.4Not reported84.396.5Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG002
        lower Limit
        86.2
        upper Limit
        94.4
        value
        90.3
      2. group Id
        OG003
        lower Limit
        90.0
        upper Limit
        96.6
        value
        93.3
    denoms
    1. counts
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
      3. group Id
        OG002
        value
        227
      4. group Id
        OG003
        value
        237
      units
      Participants
    title
    IFRT vs PFRT
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        78.4
        upper Limit
        92.6
        value
        85.5
      2. group Id
        OG001
        lower Limit
        84.3
        upper Limit
        96.5
        value
        90.4
    denoms
    1. counts
      1. group Id
        OG000
        value
        116
      2. group Id
        OG001
        value
        110
      3. group Id
        OG002
        value
        0
      4. group Id
        OG003
        value
        0
      units
      Participants
    title
    LDCSI vs SDCSI
denoms
  1. counts
    1. group Id
      OG000
      value
      116
    2. group Id
      OG001
      value
      110
    3. group Id
      OG002
      value
      227
    4. group Id
      OG003
      value
      237
    units
    Participants
description
OS was defined as the time interval from date of study entry to date of death from any cause or to the date of last follow-up for survivors. OS was estimated using the method of Kaplan and Meier. 3-year estimates are reported with 95% CI's. For purposes of this analysis, arms I, III and V (involved field radiation therapy \[IFRT\]) are combined and compared to arms II, IV and VI (posterior fossa irradiation \[PFRT\]).
dispersion Type
95% Confidence Interval
groups
  1. description
    Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II)
    id
    OG000
    title
    Low-dose Craniospinal Radiation (LDSCI)
  2. description
    Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV)
    id
    OG001
    title
    Standard-dose Craniospinal Radiation (SDCSI)
  3. description
    Includes eligible patients 3-21 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the IFRT arms (Treatment Arms I, III, V)
    id
    OG002
    title
    Involved Field Radiation (IFRT)
  4. description
    Includes eligible patients 3-21 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the PFRT arms (Treatment Arms II, IV, VI)
    id
    OG003
    title
    Posterior Fossa Radiation (PFRT)
param Type
NUMBER
population Description
Per protocol only eligible \& evaluable pts were included.Pts with anaplastic histology or disseminated/excess residual disease were not evaluable (NE). 26/23 IFRT/PFRT pts were NE, leaving 227 vs 237 for this comparison. The LD/SD CSI comparison was done only in pts 3-7 yrs of age. 11/8 LD/SDCSI pts were NE, leaving 116 vs 110 for this comparison.
reporting Status
POSTED
time Frame
3 years
title
Overall Survival (OS)
type
PRIMARY
unit Of Measure
Probability of 3 yr OS rate

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice